Please login to the form below

Not currently logged in
Email:
Password:

Lilly plans to cut 500 jobs

Eli Lilly & Co announced on April 16 that it plans to axe 500 jobs in the US as part of a company cost cutting plan that includes reducing the amount of investment in some areas of R&D.

Eli Lilly & Co announced on April 16 that it plans to axe 500 jobs in the US as part of a company cost cutting plan that includes reducing the amount of investment in some areas of R&D.

In a move the company is referring to as streamlining of its manufacturing operations in Indianapolis in the US, Lilly is offering voluntary redundancy to its employees. Although most of the job cuts will occur in manufacturing, a small number of R&D personnel will be made redundant. Lilly claims that it is offering redundancy pay packages to all employees who volunteer for what it calls an 'exit program.'

Dr John Lechleiter, president and chief executive officer (CEO) of Lilly, said: "While these are necessary decisions, they are difficult because they affect our people. From a peak employment level in mid-2004, we have reduced our global headcount by 12 per cent, or about 5,500 people."

"We are intent on upholding the Lilly values by treating all employees - particularly those directly affected by these changes - fairly and with the utmost respect," he added.

The job cuts take place at sites that manufacture Lilly's insulin products Humalog and Humulin as well as its osteoporosis medicine Forteo.

16th April 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively....

Infographics